Immunizations in children with chronic kidney disease

被引:0
作者
Alicia M. Neu
机构
[1] The Johns Hopkins University School of Medicine,Pediatric Nephrology
来源
Pediatric Nephrology | 2012年 / 27卷
关键词
Children; Kidney; Dialysis; Transplantation; Immunization; Vaccination;
D O I
暂无
中图分类号
学科分类号
摘要
Children with chronic kidney disease (CKD) are at increased risk for vaccine-preventable diseases. These patients may have a reduced response to and/or reduced duration of antibody after immunization and therefore monitoring of antibody levels or titers is indicated for some vaccines. In addition, pediatric CKD patients require immunizations not routinely provided to healthy children. Unfortunately, studies in pediatric CKD patients, including those on dialysis and awaiting kidney transplantation, have demonstrated sub-optimal immunization rates. In order to minimize the risk for vaccine-preventable disease in pediatric CKD patients, it is imperative that all who care for these patients remain abreast of the recommended childhood immunization schedule, as well as alterations to this schedule required for children with CKD, including end-stage kidney disease. This article reviews recent changes to the recommended childhood immunization schedule and alterations and additions to this schedule recommended for children with CKD. Where available, data on antibody response to immunizations in children with CKD are presented.
引用
收藏
页码:1257 / 1263
页数:6
相关论文
共 133 条
[1]  
Ghio L(2011)Recommended childhood and adolescent immunization schedules United States, 2011 Pediatrics 127 387-388
[2]  
Pedrazzi C(2011)Recommended immunization schedules for persons aged 0 through 18 years---United States, 2011 MMWR Morb Mortal Wkly Rep 60 1-4
[3]  
Assael BM(2011)Updated recommendations for use of meningococcal conjugate vaccines—Advisory Committee on Immunization Practices (ACIP), 2010 MMWR Morb Mortal Wkly Rep 60 72-76
[4]  
Panuccio A(2010)Prevention of pneumococcal disease among infants and children—use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Morb Mortal Wkly Rep 59 1-18
[5]  
Foti M(2010)Policy Statement-Recommendations for the prevention of Pediatrics 126 186-190
[6]  
Edefonti A(1997) infections in infants and children: use of 13-valent pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide vaccine (PPSV23) J Pediatr 130 987-989
[7]  
Girndt M(1995)Immunity to diphtheria and tetanus in a young population on a dialysis regimen or with a renal transplant Am J Kidney Dis 26 454-460
[8]  
Pietsch M(2000)Tetanus immunization and its association to hepatitis B vaccination in patients with chronic renal failure Semin Dial 13 101-107
[9]  
Kohler H(1997)Vaccine recommendations for patients on chronic dialysis. The Advisory Committee on Immunization Practices and the American Academy of pediatrics Adv Perit Dial 13 297-299
[10]  
Rangel MC(1997)Antibody levels to diphtheria, tetanus, and rubella in infants vaccinated while on PD: A study of the Pediatric Peritoneal Dialysis Study Consortium MMWR Morb Mortal Wkly Rep 46 1-25